4.4 Review

Inflammasome signalling in brain function and neurodegenerative disease

Journal

NATURE REVIEWS NEUROSCIENCE
Volume 19, Issue 10, Pages 610-621

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41583-018-0055-7

Keywords

-

Categories

Funding

  1. Deutsche Forschungsgesellschaft (DFG) [DFG SFBs 1089, DFG SFBs 645, DFG SFBs 670, DFG SFBs 1123, TRRs 83, TRRs 57]
  2. US National Institutes of Health [1R01HL112661]
  3. European Research Council Consolidator grant (InflammAct)
  4. DFG
  5. European Union Joint Programme-Neurodegenerative Disease (JPND) consortium InCure [01ED1505A]

Ask authors/readers for more resources

The mammalian CNS is an intricate and fragile structure, which on one hand is open to change in order to store information, but on the other hand is vulnerable to damage from injury, pathogen invasion or neurodegeneration. During senescence and neurodegeneration, activation of the innate immune system can occur. Inflammasomes are signalling complexes that regulate cells of the immune system, which in the brain mainly includes microglial cells. In microglia, the NLRP3 (NOD-, LRR- and pyrin domain-containing 3) inflammasome becomes activated when these cells sense proteins such as misfolded or aggregated amyloid-beta, alpha-synuclein and prion protein or superoxide dismutase, ATP and members of the complement pathway. Several other inflammasomes have been described in microglia and the other cells of the brain, including astrocytes and neurons, where their activation and subsequent caspase 1 cleavage contribute to disease development and progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available